A detailed history of Mackenzie Financial Corp transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 16,497 shares of TGTX stock, worth $532,193. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,497
Previous 10,782 53.01%
Holding current value
$532,193
Previous $191,000 101.57%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$17.21 - $25.28 $98,355 - $144,475
5,715 Added 53.01%
16,497 $385,000
Q1 2024

May 10, 2024

BUY
$13.02 - $21.3 $140,381 - $229,656
10,782 New
10,782 $163,000
Q2 2023

Aug 03, 2023

BUY
$15.48 - $35.0 $93,700 - $211,855
6,053 Added 47.53%
18,788 $466,000
Q1 2023

Apr 24, 2023

BUY
$10.23 - $19.34 $130,279 - $246,294
12,735 New
12,735 $191,000
Q4 2021

Feb 14, 2022

SELL
$15.2 - $35.51 $113,802 - $265,863
-7,487 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$21.78 - $40.45 $163,066 - $302,849
7,487 New
7,487 $249,000
Q4 2020

Feb 10, 2021

SELL
$25.27 - $54.9 $807,123 - $1.75 Million
-31,940 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$18.49 - $27.24 $590,570 - $870,045
31,940 New
31,940 $855,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.69B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.